KR20140138208A - 4-알카노일아미노-3-피라졸론 유도체 - Google Patents
4-알카노일아미노-3-피라졸론 유도체 Download PDFInfo
- Publication number
- KR20140138208A KR20140138208A KR1020147026675A KR20147026675A KR20140138208A KR 20140138208 A KR20140138208 A KR 20140138208A KR 1020147026675 A KR1020147026675 A KR 1020147026675A KR 20147026675 A KR20147026675 A KR 20147026675A KR 20140138208 A KR20140138208 A KR 20140138208A
- Authority
- KR
- South Korea
- Prior art keywords
- group
- dihydro
- oxo
- pyrazol
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 0 CC(*c(cc1)ncc1C(Nc1ccc(C2CCCCC2)cc1)=O)NC=C(*(C)C(C)C(C)=*)C(C)=O Chemical compound CC(*c(cc1)ncc1C(Nc1ccc(C2CCCCC2)cc1)=O)NC=C(*(C)C(C)C(C)=*)C(C)=O 0.000 description 2
- QSGSFCOIHUVRNG-UHFFFAOYSA-N CC(NC(C1=O)=CNN1c(nc1)ccc1C(NCc1cc(-c2ccccc2)ccc1)=O)=O Chemical compound CC(NC(C1=O)=CNN1c(nc1)ccc1C(NCc1cc(-c2ccccc2)ccc1)=O)=O QSGSFCOIHUVRNG-UHFFFAOYSA-N 0.000 description 1
- GDRROPJUMATIQT-UHFFFAOYSA-N CCN(C)CC(C)C(C)SC Chemical compound CCN(C)CC(C)C(C)SC GDRROPJUMATIQT-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012079858 | 2012-03-30 | ||
| JPJP-P-2012-079858 | 2012-03-30 | ||
| PCT/JP2013/059656 WO2013147215A1 (ja) | 2012-03-30 | 2013-03-29 | ４－アルカノイルアミノ－３－ピラゾロン誘導体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20140138208A true KR20140138208A (ko) | 2014-12-03 |
Family
ID=49260456
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020147026675A Withdrawn KR20140138208A (ko) | 2012-03-30 | 2013-03-29 | 4-알카노일아미노-3-피라졸론 유도체 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9212170B2 (enExample) |
| EP (1) | EP2832733B1 (enExample) |
| JP (1) | JP6126078B2 (enExample) |
| KR (1) | KR20140138208A (enExample) |
| CN (1) | CN104321318A (enExample) |
| CA (1) | CA2869130A1 (enExample) |
| ES (1) | ES2699404T3 (enExample) |
| HK (1) | HK1204621A1 (enExample) |
| IN (1) | IN2014MN01988A (enExample) |
| TW (1) | TW201400470A (enExample) |
| WO (1) | WO2013147215A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2017114765A (ja) * | 2014-04-25 | 2017-06-29 | 大正製薬株式会社 | トリアゾリルで置換されたヘテロアリール化合物 |
| CN112375072B (zh) * | 2020-09-28 | 2021-05-28 | 上海长征富民金山制药有限公司 | 吡唑啉酮衍生物、注射剂及其用途 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102008020113A1 (de) | 2008-04-23 | 2009-10-29 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Dihydropyrazolone und ihre Verwendung |
| DE102005019712A1 (de) | 2005-04-28 | 2006-11-09 | Bayer Healthcare Ag | Dipyridyl-dihydropyrazolone und ihre Verwendung |
| DE102006050516A1 (de) | 2006-10-26 | 2008-04-30 | Bayer Healthcare Ag | Substituierte Dihydropyrazolone und ihre Verwendung |
| DE102006050515A1 (de) | 2006-10-26 | 2008-04-30 | Bayer Healthcare Ag | Substituierte Dipyridiyl-dihydropyrazolone und ihre Verwendung |
| DE102007044032A1 (de) | 2007-09-14 | 2009-03-19 | Bayer Healthcare Ag | Substituierte heterocyclische Verbindungen und ihre Verwendung |
| EP2284159A4 (en) | 2008-04-22 | 2012-06-13 | Daiichi Sankyo Co Ltd | 5-hydroxypyrimidine-4-carboxamide compound |
| AU2009334570B2 (en) * | 2008-12-29 | 2016-06-09 | Sanofi | Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof |
| ES2481042T3 (es) * | 2008-12-29 | 2014-07-29 | Sanofi | Derivados de 2-piridin-2-il-pirazol-3(2H)-ona, su preparación y uso terapéutico como activadores de HIF |
| JP2011105708A (ja) * | 2009-10-21 | 2011-06-02 | Daiichi Sankyo Co Ltd | ５−ヒドロキシピリミジン−４−カルボキサミド化合物を含有する医薬組成物 |
| JP2011088840A (ja) * | 2009-10-21 | 2011-05-06 | Daiichi Sankyo Co Ltd | ５−ヒドロキシピリミジン−４−カルボキサミド化合物を含有する医薬組成物 |
-
2013
- 2013-03-29 CN CN201380028513.7A patent/CN104321318A/zh active Pending
- 2013-03-29 IN IN1988MUN2014 patent/IN2014MN01988A/en unknown
- 2013-03-29 EP EP13768519.4A patent/EP2832733B1/en not_active Not-in-force
- 2013-03-29 TW TW102111318A patent/TW201400470A/zh unknown
- 2013-03-29 KR KR1020147026675A patent/KR20140138208A/ko not_active Withdrawn
- 2013-03-29 ES ES13768519T patent/ES2699404T3/es active Active
- 2013-03-29 WO PCT/JP2013/059656 patent/WO2013147215A1/ja not_active Ceased
- 2013-03-29 JP JP2014508119A patent/JP6126078B2/ja active Active
- 2013-03-29 CA CA2869130A patent/CA2869130A1/en not_active Abandoned
- 2013-03-29 HK HK15105296.3A patent/HK1204621A1/en unknown
-
2014
- 2014-09-24 US US14/495,052 patent/US9212170B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2013147215A1 (ja) | 2015-12-14 |
| HK1204621A1 (en) | 2015-11-27 |
| IN2014MN01988A (enExample) | 2015-07-10 |
| WO2013147215A1 (ja) | 2013-10-03 |
| ES2699404T3 (es) | 2019-02-11 |
| EP2832733A4 (en) | 2015-09-30 |
| US20150011552A1 (en) | 2015-01-08 |
| EP2832733A1 (en) | 2015-02-04 |
| TW201400470A (zh) | 2014-01-01 |
| EP2832733B1 (en) | 2018-08-29 |
| JP6126078B2 (ja) | 2017-05-10 |
| US9212170B2 (en) | 2015-12-15 |
| CN104321318A (zh) | 2015-01-28 |
| CA2869130A1 (en) | 2013-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102388312B1 (ko) | 아미노피리미딘 화합물, 이의 제조방법 및 용도 | |
| CN117209447A (zh) | 用于治疗与nlrp活性相关的病症的化合物和组合物 | |
| US8183242B2 (en) | Aminopyrimidine compounds and their salts, process for preparation and pharmaceutical use thereof | |
| JP2017531679A (ja) | キナーゼ阻害剤として有用なインドールカルボキシアミド | |
| CN104341425B (zh) | 氘代乙炔衍生物、其药物组合物及应用 | |
| TWI669300B (zh) | 嘧啶類衍生物、其製備方法、其藥物組合物以及其在醫藥上的用途 | |
| MX2010013919A (es) | Derivados de pirrolopiridinil-pirimidin-2-il-amina. | |
| CN106220608A (zh) | 二苯氨基嘧啶及三嗪化合物、其药用组合物及用途 | |
| JP6257835B2 (ja) | 新規なトリアゾロピリミジノン又はトリアゾロピリジノン誘導体、及びこれらの用途 | |
| JP2020526557A (ja) | ムスカリン性アセチルコリン受容体ｍ４のアンタゴニスト | |
| JP2021536436A (ja) | キノリン誘導体から調製される新規な阻害剤 | |
| CN119371414A (zh) | 一类nsd蛋白降解剂及其用途 | |
| US9206168B2 (en) | (2-heteroarylamino) succinic acid derivatives | |
| WO2021018173A1 (zh) | 腺苷受体拮抗剂 | |
| KR20140138208A (ko) | 4-알카노일아미노-3-피라졸론 유도체 | |
| KR20150105302A (ko) | 헤지 호그 신호 경로의 억제제로서 환상 술폰아미드 함유 유도체 | |
| WO2025137146A1 (en) | Substituted heteroaryl analogs and uses thereof for the treatment of hiv-associated neurocognitive disorders | |
| WO2023236960A1 (zh) | 一种具有rsk抑制作用的羧酰胺衍生物、包含其的药物组合物及其用途 | |
| EA045754B1 (ru) | Аналоги пентамидина и их применение | |
| BR112019025836B1 (pt) | Composto de aminopirimidina, seu método de preparação, composição farmacêutica e seu uso |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20140924 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| PC1203 | Withdrawal of no request for examination | ||
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |